Tolterodine extended-release (ER) versus standard-dose pregabalin + tolterodine ER versus low-dose pregabalin + tolterodine ER versus pregabalin alone in female patients with idiopathic overactive bladder

Trial Profile

Tolterodine extended-release (ER) versus standard-dose pregabalin + tolterodine ER versus low-dose pregabalin + tolterodine ER versus pregabalin alone in female patients with idiopathic overactive bladder

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Mar 2011

At a glance

  • Drugs Pregabalin; Tolterodine
  • Indications Overactive bladder
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top